Cargando…

Hypermethylation of DAPK1 is an independent prognostic factor predicting survival in diffuse large B-cell lymphoma

Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin's lymphoma. Improvements in overall survival have been observed with the introduction of rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP), however, prognostic markers ar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kristensen, Lasse Sommer, Asmar, Fazila, Dimopoulos, Konstantinos, Nygaard, Mette Kathrine, Aslan, Derya, Hansen, Jakob Werner, Ralfkiaer, Elisabeth, Grønbæk, Kirsten
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4259438/ https://www.ncbi.nlm.nih.gov/pubmed/25229255

Ejemplares similares

Investigation of MGMT and DAPK1 methylation patterns in diffuse large B-cell lymphoma using allelic MSP-pyrosequencing
por: Kristensen, Lasse Sommer, et al.
Publicado: (2013)

Hypermethylation of the VTRNA1-3 Promoter is Associated with Poor Outcome in Lower Risk Myelodysplastic Syndrome Patients
por: Søgaard Helbo, Alexandra, et al.
Publicado: (2015)

Tumor suppressor microRNAs are downregulated in myelodysplastic syndrome with spliceosome mutations
por: Aslan, Derya, et al.
Publicado: (2016)

TP53 hotspot mutations are predictive of survival in primary central nervous system lymphoma patients treated with combination chemotherapy
por: Munch-Petersen, Helga D., et al.
Publicado: (2016)

Genome-Wide Circular RNA Expression Patterns Reflect Resistance to Immunomodulatory Drugs in Multiple Myeloma Cells
por: Jakobsen, Theresa, et al.
Publicado: (2021)

Dual inhibition of DNMTs and EZH2 can overcome both intrinsic and acquired resistance of myeloma cells to IMiDs in a cereblon‐independent manner
por: Dimopoulos, Konstantinos, et al.
Publicado: (2017)

Diffuse large B-cell lymphoma with combined TP53 mutation and MIR34A methylation: Another “double hit” lymphoma with very poor outcome?
por: Asmar, Fazila, et al.
Publicado: (2014)

Long Non-Coding RNAs Guide the Fine-Tuning of Gene Regulation in B-Cell Development and Malignancy
por: Dahl, Mette, et al.
Publicado: (2018)

Aberrant methylation of cell-free circulating DNA in plasma predicts poor outcome in diffuse large B cell lymphoma
por: Kristensen, Lasse Sommer, et al.
Publicado: (2016)

DNA Methylation Levels of the ELMO Gene Promoter CpG Islands in Human Glioblastomas
por: Michaelsen, Signe Regner, et al.
Publicado: (2018)

TET2 mutations are associated with hypermethylation at key regulatory enhancers in normal and malignant hematopoiesis
por: Tulstrup, Morten, et al.
Publicado: (2021)

Profiling of ribose methylations in ribosomal RNA from diffuse large B-cell lymphoma patients for evaluation of ribosomes as drug targets
por: Krogh, Nicolai, et al.
Publicado: (2020)

Clinical significance of DAPK promoter hypermethylation in lung cancer: a meta-analysis
por: Li, Ying, et al.
Publicado: (2015)

Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies
por: Dahl, Mette, et al.
Publicado: (2018)

Hypermethylation of p16 and DAPK promoter gene regions in patients with non-invasive urinary bladder cancer
por: Jabłonowski, Zbigniew, et al.
Publicado: (2011)

Hypermethylation status of DAPK, MGMT and RUNX3 in HPV negative oral and oropharyngeal squamous cell carcinoma
por: dos Reis, Raquel Silva, et al.
Publicado: (2020)

Assessment of Quantitative and Allelic MGMT Methylation Patterns as a Prognostic Marker in Glioblastoma
por: Kristensen, Lasse S., et al.
Publicado: (2016)

Publisher Correction: Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations
por: Nielsen, Helene Myrtue, et al.
Publicado: (2018)

Epigenetic changes in myelofibrosis: Distinct methylation changes in the myeloid compartments and in cases with ASXL1 mutations
por: Nielsen, Helene Myrtue, et al.
Publicado: (2017)

Concurrent Inhibition of Akt and ERK Using TIC-10 Can Overcome Venetoclax Resistance in Mantle Cell Lymphoma
por: Granau, Agnete Marie, et al.
Publicado: (2023)

The diagnostic and prognostic role of flow cytometry in idiopathic and clonal cytopenia of undetermined significance (ICUS/CCUS): A single‐center analysis of 79 patients
por: Dimopoulos, Konstantinos, et al.
Publicado: (2019)

DAPK1 as an independent prognostic marker in liver cancer
por: Li, Ling, et al.
Publicado: (2017)

Inflammatory Cytokine Profiles Do Not Differ Between Patients With Idiopathic Cytopenias of Undetermined Significance and Myelodysplastic Syndromes
por: Nielsen, Amalie Bach, et al.
Publicado: (2022)

Clonal Hematopoiesis and Epigenetic Age Acceleration in Elderly Danish Twins
por: Soerensen, Mette, et al.
Publicado: (2022)

Structural aberrations are associated with poor survival in patients with clonal cytopenia of undetermined significance
por: Mikkelsen, Stine U., et al.
Publicado: (2020)

Identification of DAPK1 Promoter Hypermethylation as a Biomarker for Intra-Epithelial Lesion and Cervical Cancer: A Meta-Analysis of Published Studies, TCGA, and GEO Datasets
por: Wang, Xue-bin, et al.
Publicado: (2018)

AMPK activates DAPK2 to promote autophagy
por: Shiloh, Ruth, et al.
Publicado: (2018)

Regulation of the Expression of DAPK1 by SUMO Pathway
por: Wang, Qingshui, et al.
Publicado: (2019)

The prognostic significance of DAPK1 in bladder cancer
por: Xie, Jian-Yun, et al.
Publicado: (2017)

Promoter hypermethylation of RARβ2, DAPK, hMLH1, p14, and p15 is associated with progression of breast cancer: A PRISMA-compliant meta-analysis
por: Qi, Ming, et al.
Publicado: (2018)

P1246: DIFFERENTIAL ROLE OF MICROENVIRONMENT AND STROMAL-CELL INDUCED VENETOCLAX RESISTANCE IN MANTLE CELL LYMPHOMA
por: Andersen, P., et al.
Publicado: (2022)

Cell‐of‐origin determined by both gene expression profiling and immunohistochemistry is the strongest predictor of survival in patients with diffuse large B‐cell lymphoma
por: Abdulla, Maysaa, et al.
Publicado: (2019)

A predictive model for bone marrow disease in cytopenia based on noninvasive procedures
por: Træden, Dicte, et al.
Publicado: (2022)

Diagnostic potential of methylated DAPK in brushing samples of nasopharyngeal carcinoma
por: Zhang, Jian, et al.
Publicado: (2018)

DAPK1 Signaling Pathways in Stroke: from Mechanisms to Therapies
por: Wang, Shan, et al.
Publicado: (2016)

Diagnostic Value of DAPK Methylation for Nasopharyngeal Carcinoma: Meta-Analysis
por: Lao, Thuan Duc, et al.
Publicado: (2023)

Development and Blind Clinical Validation of a MicroRNA Based Predictor of Response to Treatment with R-CHO(E)P in DLBCL
por: Knudsen, Steen, et al.
Publicado: (2015)

Germline Allele-Specific Expression of DAPK1 in Chronic Lymphocytic Leukemia
por: Wei, Quan-Xiang, et al.
Publicado: (2013)

DAPK interacts with Patronin and the microtubule cytoskeleton in epidermal development and wound repair
por: Chuang, Marian, et al.
Publicado: (2016)

Prognostic significance of DAPK promoter methylation in lymphoma: A meta-analysis
por: Wang, Hong, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_nmf9n23s08733oef5j27dhuenh